Drug intelligence / Profile preview

ASHMI

Development stage
Phase 2
Lead developer
Sino-Lion
Administration
Oral
01

Overview

**ASHMI** is a proprietary three-herb anti-asthma botanical drug candidate developed for the treatment of asthma, particularly allergic asthma. It was studied under a United States FDA Investigational New Drug framework and in clinical trials led by Icahn School of Medicine at Mount Sinai. Published clinical context describes ASHMI as an oral capsule formulation manufactured by Sino-Lion Pharmaceutical and designed as a Chinese herbal medicine intervention with immunomodulatory anti-asthma activity rather than a defined single-molecule target mechanism. In a phase I randomized placebo-controlled dose-escalation study in adults with allergic asthma, ASHMI appeared safe and well tolerated, which supported subsequent phase II evaluation for asthma efficacy.

Brand names
ASHMI
Other names
anti-asthma herbal medicine intervention
02

Targets

IL-4 (Interleukin 4)IL-5 (Interleukin 5)NF-κBPTGER2 (Prostaglandin E2 receptor EP2)PTGER4 (Prostaglandin E2 receptor EP4 subtype)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on ASHMI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASHMI.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call